AbbVie
ABBV
#28
Rank
S$403.07 B
Marketcap
$227.86
Share price
2.13%
Change (1 day)
-0.35%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: S$403.07 Billion

As of April 2025 AbbVie has a market cap of S$403.07 Billion. This makes AbbVie the world's 28th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025S$403.07 B-5.73%
2024S$427.58 B18.33%
2023S$361.35 B-5.69%
2022S$383.14 B18.4%
2021S$323.60 B29.31%
2020S$250.26 B41.76%
2019S$176.53 B-5.22%
2018S$186.25 B-9.8%
2017S$206.49 B40.21%
2016S$147.28 B9.18%
2015S$134.90 B-1.96%
2014S$137.60 B29.56%
2013S$106.20 B60.91%
2012S$66.00 B

End of Day market cap according to different sources

On Apr 22nd, 2025 the market cap of AbbVie was reported to be:

S$409.77 Billion
by Yahoo Finance info icon info icon
S$409.77 Billion
by CompaniesMarketCap info icon info icon
S$402.41 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$167.53 B-58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$132.91 B-67.02%๐Ÿ‡บ๐Ÿ‡ธ USA
S$974.36 B 141.73%๐Ÿ‡บ๐Ÿ‡ธ USA
S$196.26 B-51.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$172.46 B-57.21%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.81 B-94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
S$97.30 B-75.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$275.90 B-31.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$13.19 B-96.73%๐Ÿ‡บ๐Ÿ‡ธ USA